❯less venture-capital-term-sheet.md
Reading a VC Term Sheet: Economics, Control, and Closing
A venture capital term sheet records the principal terms of a proposed financing. In a U.S. priced preferred-stock round, it usually provides the framework for negotiation and definitive agreements, but some provisions may be intended to bind the parties when they sign.
Overview
Signing the term sheet is not the same as closing the round or receiving funds. Carta describes a term sheet as a preliminary document that establishes the basis for further negotiation and detailed legal paperwork. The investor and company still need to complete diligence, prepare definitive documents, obtain required approvals, satisfy closing conditions, sign, and fund the transaction.
Read a VC term sheet in three passes:
1. Economics: What ownership will each party have, and how will proceeds be distributed?
2. Control: Who can elect directors, approve corporate actions, or block specified decisions?
3. Deal process: What becomes binding, what work remains, and what could prevent or delay closing?
These categories interact. A higher valuation can lose some of its apparent benefit through a larger pre-money option pool or participating liquidation preference. A founder-controlled board may not provide practical freedom if preferred stockholders have separate veto rights. A mostly nonbinding term sheet may still impose an enforceable no-shop restriction or expense obligation.
The goal before signing is therefore not to label the term sheet good or bad. It is to trace every important clause to its effect on ownership, payout, control, or closing. Experienced U.S. venture-financing counsel should then apply that analysis to the actual language, governing law, capitalization, and company circumstances.
Where a term sheet fits in a priced venture round
A priced-round term sheet sits between initial financing discussions and the definitive agreements that legally implement the investment. It records the proposed principal terms so the company and investor can decide whether to spend further time and money completing the transaction.
The parties may negotiate the investment amount, valuation, security, liquidation rights, board structure, investor protections, expenses, exclusivity, and closing process. Once they sign, the proposed financing ordinarily moves into diligence, documentation, approvals, and closing. As Hustle Fund explains, the term sheet starts a process rather than replacing it.
A representative priced preferred-stock document set can include a stock purchase agreement, investor rights agreement, amended certificate of incorporation, right of first refusal and co-sale agreement, and voting agreement. Silicon Valley Bank identifies these documents as part of the documentation that may follow a term sheet. Each performs a different legal job, so the short term-sheet description must eventually be translated into complete provisions across the final documents.
A priced-round term sheet should also be distinguished from a SAFE or convertible note. A SAFE or note is a financing instrument with its own terms. A term sheet for a priced round instead proposes the terms on which preferred stock will be issued through later definitive agreements. The treatment of an outstanding SAFE or note may still affect the priced round because its conversion can change the capitalization used to calculate ownership.
The term sheet is therefore neither the financing instrument nor the final document set. It is the negotiated bridge between an investment proposal and the documents, approvals, and actions required to close it.
What may be binding
The principal financing terms are often expressly described as nonbinding, but that statement may not apply to every provision. A term sheet can designate confidentiality, exclusivity, governing law, and expense treatment as binding even when the proposed investment itself remains subject to definitive agreements.
Start with the term sheet’s own language. Identify which paragraphs are expressly binding, whether the parties are expected to sign, when each obligation begins, how it terminates, and which law governs it. A broad statement that the term sheet is nonbinding may sit alongside specific language creating immediate obligations.
Governing law matters because courts apply jurisdiction-specific contract rules. In a July 2025 analysis of Delaware law, Mayer Brown explains that designated binding provisions can sometimes remain effective after the parties execute a definitive agreement. That can occur even when the later agreement contains an integration clause, depending on its wording, subject matter, any conflicting provisions, and evidence of the parties’ intent.
Under the Delaware cases discussed by Mayer Brown, a later definitive agreement may supersede a binding term-sheet provision to the extent the two conflict. The parties may also expressly state that the term sheet terminates. But a general integration clause does not necessarily erase every earlier obligation if its language and scope leave room for the binding provision to survive.
That Delaware analysis should not be turned into a rule for every U.S. jurisdiction. Counsel should determine the effect of the chosen governing law and the exact documents. The practical questions are concrete: Does the final agreement expressly terminate the term sheet? Does it preserve confidentiality or another obligation? Does it address the same subject matter? Does an earlier expense or exclusivity commitment remain outside the final agreement?
This review matters before signing, not only at closing. A company may become restricted from pursuing another financing while the investor remains free to complete diligence and negotiate definitive terms. The economic proposal may still be conditional, but the process obligation can already be real.
Economics: valuation, ownership, and dilution
The headline valuation does not determine ownership by itself. The investment amount, capitalization definition, price per share, option-pool treatment, and treatment of outstanding securities must reconcile in one model.
In a simple priced financing, post-money valuation equals pre-money valuation plus the new investment. Wall Street Prep states this relationship for a basic priced round. A $2 million investment at an $8 million pre-money valuation therefore produces a $10 million post-money valuation.
Under those simplified assumptions, the investor would own:
$2 million ÷ $10 million = 20%
That percentage holds only if the capitalization definition and share calculations match the simple formula. The term sheet may calculate the price per share using a “fully diluted” pre-money capitalization that includes more than the shares currently issued to founders and employees.
The basic price-per-share relationship is:
Pre-money valuation ÷ pre-money fully diluted shares = price per share
The investor’s share count is then:
Investment amount ÷ price per share = investor shares
The denominator matters. Review exactly what the term sheet includes in fully diluted capitalization, such as issued shares, granted options, the unallocated option pool, and securities or commitments treated as converting into equity. The relevant definitions and the underlying documents determine the result.
Option-pool timing is especially consequential. If the company must increase its employee equity pool before the financing, the additional shares usually enter the pre-money capitalization and dilute existing holders. If the increase occurs after the financing, the new investor shares part of that dilution. Hustle Fund highlights this distinction in its term-sheet review framework.
Ownership should therefore be checked from the share count upward, not inferred from valuation alone. Reconcile the proposed price per share, investor shares, post-closing option pool, and every holder’s percentage to the same capitalization definition.
Worked example: who pays for the option pool?
Creating the employee option pool before the investment leaves the founders with 70% in this example. Creating it afterward leaves them with 72%, because the new investor shares the dilution. The same headline valuation can therefore produce different ownership outcomes.
Both scenarios use these assumptions:
- The founders own 8 million shares before either transaction.
- The investor puts in $2 million at an $8 million pre-money valuation.
- The new, unallocated employee pool must equal 10% of the fully diluted shares after both steps.
- There is no existing pool, other stockholder, SAFE, note, warrant, promised grant, or other equity commitment.
Pool created before the investment
The investor receives 20% after the financing, and the employee pool reserves 10%. That leaves 70% for the founders.
The founders' 8 million shares must therefore equal 70% of the final total. Dividing 8 million by 0.70 gives approximately 11.43 million fully diluted shares: 8 million founder shares, 1.14 million pool shares, and 2.29 million investor shares.
The investor's price per share is $0.875. The pool enters the share count before that price is set, so the founders bear the pool's dilution.
Pool created after the investment
The investor first buys 2 million shares at $1 each. At that point, there are 10 million shares: founders own 80% and the investor owns 20%.
Creating a pool equal to 10% of the final total reduces both existing stakes by one tenth. Founder ownership becomes 80% × 90% = 72%; investor ownership becomes 20% × 90% = 18%. The pool holds the remaining 10%.
To size that pool, divide the existing 10 million shares by 0.90. The final total is approximately 11.11 million fully diluted shares, including approximately 1.11 million pool shares.
What to check in your term sheet: whether the option-pool increase is included before the investment price is calculated. In this simplified example, that timing changes founder ownership by two percentage points. Share counts above are rounded for readability; the ownership percentages use the unrounded calculations.
This is an illustration, not a benchmark or prediction of a particular deal. A real capitalization may include outstanding SAFEs, convertible notes, warrants, granted options, promised grants, or other commitments. Each item must be added according to its own documents and the term sheet's capitalization definition. Counsel and the company's cap-table owner should confirm which instruments convert, at what price, and whether their shares are included before or after the financing price is calculated.
Rights that affect future rounds and stockholder access
Investor rights can change the economics and mechanics of later financings without changing the initial headline valuation. Anti-dilution and pro rata rights are especially easy to confuse, but they solve different problems.
An anti-dilution provision can adjust the preferred stock’s conversion price when the company later issues securities at a lower price, subject to the formula and exceptions in the documents. It is conversion-price protection. It does not automatically preserve the investor’s ownership percentage against every future issuance.
A pro rata right gives an eligible investor an opportunity to purchase securities in a later financing, subject to the stated conditions. Exercising that right requires the investor to contribute additional capital. If the investor does not exercise, cannot satisfy an eligibility threshold, or the issuance falls outside the right, its ownership may still decline.
Read these rights through their mechanics rather than their labels. For anti-dilution, identify the adjustment formula, which issuances trigger it, and which issuances are excluded. For pro rata rights, identify who qualifies, how the allocation is calculated, the notice process, the exercise deadline, and whether the right ends below a stated ownership threshold.
Information rights determine what company information an investor can receive under the definitive agreement. The practical scope depends on the defined recipients, reporting requirements, thresholds, exceptions, and duration. Confirm what the company must deliver, to whom, and on what schedule before accepting an operational burden.
Transfer provisions regulate how stockholders can sell or transfer shares. A right of first refusal can give the company or another specified party the opportunity to purchase shares before a proposed transfer proceeds. Co-sale and other related rights may affect whether other holders can participate in that transfer. Carta groups these provisions among the economic, control, and transfer rights that term sheets commonly address.
The key distinction is that these provisions do not freeze the cap table. Anti-dilution may change conversion economics, while pro rata rights create an opportunity to invest more. Neither is a general promise that the investor’s percentage will remain constant. Model the actual future issuance and apply the formulas, thresholds, exceptions, and exercise requirements in the proposed documents.
Exit economics: liquidation preference and participation
Liquidation preference determines how proceeds available to stockholders are distributed in a defined liquidation event, such as a sale or wind-down. The outcome depends on the preference multiple, participation rights, conversion choice, seniority, dividends, and the amount left after higher-priority claims.
A 1x preference generally describes a preferred claim based on one times the original investment. It does not guarantee repayment. Debt, transaction expenses, senior securities, and limited proceeds can reduce what remains for preferred and common stockholders.
With 1x non-participating preferred, an investor generally compares the preference amount with the amount it would receive after converting to common stock. The investor takes the result permitted by the documents that produces the larger payout. Hustle Fund explains this basic choice, while emphasizing that the actual waterfall and available proceeds control.
Participating preferred works differently. The investor may receive its preference first and then share in the remaining proceeds on an as-converted basis. Y Combinator describes participating preferred as allowing the investor to receive its money back plus its pro rata portion of exit proceeds, rather than choosing between the two. Participation may be capped or otherwise limited, so the exact provision matters.
Seniority determines the order among different preferred classes. A senior class may receive its claim before a junior class participates. Pari passu classes share at the same priority according to the governing terms. Any dividend provision can also affect the amount claimed if the documents provide for an accrued or declared amount to enter the waterfall.
The valuation at financing still matters, but it cannot answer the payout question alone. Two deals with identical investment amounts and ownership percentages can distribute the same exit proceeds differently because one security participates and the other does not.
Worked exit waterfalls
Assume one investor contributes $2 million and owns 20% on an as-converted basis. Its security has a 1x liquidation preference. The comparison is between non-participating preferred and uncapped participating preferred.
For clarity, debt, transaction expenses, accrued dividends, and senior claims are each assumed to be $0. Gross exit proceeds therefore equal proceeds available to stockholders. All other preferred-stock terms are held constant. These figures illustrate the mechanics and are not market benchmarks.
- Gross exit proceeds: $3,000,000
Deductions before stockholders: $0 debt + $0 expenses + $0 senior claims = $0
1x non-participating investor payout: Max($2,000,000 preference, 20% × $3,000,000) = $2,000,000
Non-participating common payout: $3,000,000 − $2,000,000 = $1,000,000
Uncapped participating investor payout: $2,000,000 + 20% × ($3,000,000 − $2,000,000) = $2,200,000
Participating common payout: $3,000,000 − $2,200,000 = $800,000 - Gross exit proceeds: $12,000,000
Deductions before stockholders: $0 debt + $0 expenses + $0 senior claims = $0
1x non-participating investor payout: Max($2,000,000 preference, 20% × $12,000,000) = $2,400,000
Non-participating common payout: $12,000,000 − $2,400,000 = $9,600,000
Uncapped participating investor payout: $2,000,000 + 20% × ($12,000,000 − $2,000,000) = $4,000,000
Participating common payout: $12,000,000 − $4,000,000 = $8,000,000 - Gross exit proceeds: $30,000,000
Deductions before stockholders: $0 debt + $0 expenses + $0 senior claims = $0
1x non-participating investor payout: Max($2,000,000 preference, 20% × $30,000,000) = $6,000,000
Non-participating common payout: $30,000,000 − $6,000,000 = $24,000,000
Uncapped participating investor payout: $2,000,000 + 20% × ($30,000,000 − $2,000,000) = $7,600,000
Participating common payout: $30,000,000 − $7,600,000 = $22,400,000
At the $12 million exit, participation increases the investor’s illustrated payout from $2.4 million to $4 million. The difference is $1.6 million even though the investment amount, valuation-derived ownership, and exit value are unchanged.
A real waterfall can produce a different result if it includes debt, expenses, multiple preferred classes, seniority, accrued dividends, participation caps, carve-outs, or other claims. Build the waterfall in the order stated by the documents and show each deduction before comparing the preferred claim with conversion.
Control: board seats, vetoes, and stockholder approvals
Control in a venture capital term sheet comes through several mechanisms. Board composition, director voting, preferred-stockholder protective provisions, voting agreements, and drag-along rights can each affect different decisions.
A board seat gives a director a vote on matters presented to the board. The director also has fiduciary duties to the corporation and its stockholders. A preferred-stockholder veto is different: it is a contractual or charter-based approval right held by a class or group of stockholders over specified actions. Hustle Fund makes this distinction directly.
That separation has practical consequences. A board may approve a transaction, yet the company may still need a separate preferred-stockholder vote under the protective provisions. Conversely, an investor-appointed director may vote on a board matter that does not trigger a class veto.
Map each control term to the body that exercises it:
- Board composition: Identify the number of seats, who designates each director, how vacancies are filled, and whether an independent director requires mutual approval.
- Protective provisions: Identify which corporate actions require approval from a preferred class, a specified percentage of that class, or another investor group.
- Voting agreement: Determine how stockholders have agreed to vote for directors or on other covered matters.
- Drag-along provision: Determine when specified holders can require other stockholders to support an approved sale and what conditions must be met.
Do not evaluate a board structure by counting founder and investor seats alone. Ask what vote is needed for board action, whether any seat can remain vacant, how an independent director is selected, and whether committees have delegated authority. A nominal majority may not control a decision that requires a separate investor approval.
Protective provisions should be read action by action. Carta describes them as preferred-stockholder veto rights over specified company decisions. The actual list and thresholds determine their reach. Focus on which actions require consent, whether the right belongs to all preferred holders or a particular series, and whether the right ends when ownership falls below a threshold.
Board examples in public templates are reference points, not universal structures. Y Combinator’s Series A form discusses both a founder-controlled 2-1 board and a 2-2-1 structure with an independent director, but its description is tied to that template and its own perspective. The correct arrangement for a particular financing must be evaluated with the voting thresholds, protective provisions, stockholder agreements, and company circumstances beside it.
Deal process: exclusivity, diligence, documents, and closing
Signing a term sheet begins the transaction process. It does not create an unconditional funding commitment when the financing terms remain nonbinding and subject to diligence, definitive agreements, approvals, and closing conditions.
The acceptance provision determines how and when the company must agree to the proposal. Once accepted, any binding exclusivity or no-shop obligation may limit the company’s ability to seek or discuss alternative financing. That restriction can reduce practical negotiating leverage before the investor has completed the steps required to fund.
Read exclusivity as an operating constraint. Identify when it starts, when it ends, what discussions or actions it prohibits, whether existing conversations are addressed, who can consent to an exception, and whether the period can be extended. Its legal effect depends on the wording and governing law, as does any remedy for breach.
Expense provisions deserve the same attention. Determine which party pays legal and transaction costs, whether reimbursement is conditioned on closing, whether a cap applies, and whether an obligation survives termination. Do not assume an expense clause disappears when negotiations stop or definitive agreements are signed.
During diligence, the investor may review the company and financing assumptions before deciding whether to close. In parallel, counsel translates the term sheet into the stock purchase agreement, amended certificate, investor rights agreement, voting agreement, and transfer-related documents. The parties negotiate details that the term sheet may have described only briefly.
Company and investor approvals then need to be obtained under the applicable documents. Closing also depends on the stated conditions being satisfied or waived by the party entitled to do so. A target closing date is therefore not the same as a promise that funds will arrive on that date.
At closing, the parties execute the documents, the investor wires funds, and the company issues the securities. The cap table and corporate records are then updated, followed by required filings and post-closing obligations. Hustle Fund summarizes this sequence as the point at which funding and issuance actually occur.
Four dates that should not be confused
A term sheet can contain several dates or periods that serve different purposes. Put them on one calendar, along with the conditions, extension rights, and termination language attached to each.
- Date or period: Term-sheet acceptance deadline
What it controls: How long the proposal remains open for acceptance
What to extract from the documents: Exact deadline, time zone, required signature or notice, and whether the investor can withdraw earlier
Why it matters: Missing it may end the current proposal or require renewed agreement - Date or period: No-shop or exclusivity period
What it controls: When restrictions on alternative financing discussions apply
What to extract from the documents: Start event, end date, prohibited conduct, exceptions, consent rights, extensions, and termination
Why it matters: The company may lose access to alternatives before financing closes - Date or period: Diligence and drafting period
What it controls: When investigation, document preparation, approvals, and negotiation occur
What to extract from the documents: Requested materials, responsible parties, unresolved conditions, approval path, and document timetable
Why it matters: Signing alone does not complete these steps - Date or period: Closing or funding date
What it controls: When definitive documents are signed and the investment is funded
What to extract from the documents: Target versus fixed date, closing conditions, waiver rights, wire mechanics, and termination rights
Why it matters: A target date can move if a required condition remains unsatisfied
There is no single duration to insert for any of these periods. The operative dates come from the term sheet, definitive documents, closing checklist, and communications that modify them. Confirm amendments in writing and make sure the closing calendar matches the binding obligations.
How to review and negotiate before signing
Review the term sheet as one connected package. Reconcile the cap table first, model the exit waterfall second, map control rights third, and then trace the binding provisions, deadlines, documentation, and closing conditions.
The cap-table model should use the same investment amount, pre-money valuation, price per share, option-pool treatment, and fully diluted capitalization stated in the term sheet. It should also account for outstanding securities and equity commitments according to their governing documents. A model that reaches a different investor ownership percentage than the term sheet has found an issue that must be resolved.
Next, run several exit values through the liquidation waterfall. Include debt, expenses, senior claims, preference multiples, participation, conversion, dividends, and each class’s seniority. This step tests payout consequences that cannot be seen from valuation alone.
Then build a control map. Separate board decisions from preferred-stockholder approvals and general stockholder votes. Add the voting agreement, drag-along mechanics, transfer restrictions, and any thresholds that cause rights to begin or end.
Finally, mark every provision described as binding and put every deadline on a calendar. Match the proposed terms to the definitive documents expected to implement them, then identify diligence requirements, approval dependencies, closing conditions, expense exposure, and termination rights.
- Clause or issue: Investment, valuation, and price per share
Primary consequence: Ownership and dilution
Model or document check: Reconcile all three figures against the same fully diluted share count
Question to resolve before signing: Does the calculated investor percentage match the stated percentage? - Clause or issue: Option pool and capitalization definition
Primary consequence: Who bears dilution
Model or document check: Compare pre-money and post-money pool treatment; include every security or commitment counted in the denominator
Question to resolve before signing: Which shares, options, convertibles, warrants, and promised grants are included before the price is set? - Clause or issue: Liquidation preference, participation, dividends, and seniority
Primary consequence: Exit payout
Model or document check: Run low, middle, and higher exit waterfalls after debt, expenses, and senior claims
Question to resolve before signing: When does the investor take the preference, participate, convert, or receive a dividend amount? - Clause or issue: Board composition and voting agreement
Primary consequence: Board-level control
Model or document check: Map seats, designation rights, vacancies, voting thresholds, and independent-director selection
Question to resolve before signing: Who can approve or block each board decision in practice? - Clause or issue: Protective provisions and stockholder approvals
Primary consequence: Contractual or charter-based veto power
Model or document check: List every covered action, approval group, threshold, exception, and termination trigger
Question to resolve before signing: Which actions need investor approval even after the board has approved them? - Clause or issue: Anti-dilution, pro rata, information, and transfer rights
Primary consequence: Future financing and stockholder obligations
Model or document check: Apply formulas and thresholds to a hypothetical later issuance or transfer
Question to resolve before signing: What triggers the right, what is excluded, and what must each party do to exercise it? - Clause or issue: Exclusivity, confidentiality, expenses, and governing law
Primary consequence: Pre-closing obligations
Model or document check: Mark binding language, start and end dates, survival terms, caps, and termination mechanics
Question to resolve before signing: What binds immediately, and can any obligation survive termination or definitive documents? - Clause or issue: Diligence, definitive documents, approvals, and closing conditions
Primary consequence: Timing and funding risk
Model or document check: Build a closing checklist with owners, dependencies, waiver rights, and target dates
Question to resolve before signing: What remains before funding, and who can decide that a condition has been satisfied or waived?
Prioritize the issues that materially change ownership, payout, control, obligations, or the probability and timing of closing. Silicon Valley Bank recommends identifying critical terms and areas where the company can be more flexible before negotiating.
Test each proposed change across the full package. If the valuation rises, recalculate the option pool and final ownership. If participation is removed, rerun the waterfall. If the investor gives up a board seat, check whether protective provisions still provide approval rights over the same decisions. A concession in one clause can be offset elsewhere.
Claims that a term is “market” should be tied to relevant context rather than accepted as a conclusion. Y Combinator’s Series A discussion expressly avoids setting standard pricing because price changes with the parties’ leverage and the specific raise. A public example can frame a question, but it cannot determine the right valuation, board structure, or walk-away point for a particular company.
For document references, review the NVCA model legal documents and Y Combinator’s Series A term sheet alongside the proposed language. Templates can help identify missing concepts and show how a term may flow into the final document set. They are starting points, not substitutes for company-specific drafting and advice.
Before signing, send counsel the reconciled cap table, exit waterfalls, control map, marked binding provisions, and closing calendar. That gives the legal review concrete questions to answer and keeps the negotiation focused on consequences rather than labels.
(END) — back to blog/ · pitch us
next: How to Plan a Pre-Seed Raise From Readiness to Closing →